Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Milestone Pharmaceuticals Inc. (MIST) is a Biotechnology company based in CA with a market capitalization of $99.6M. Free cash flow was negative at -$49.3M. This page tracks MIST's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CA · 33 employees · IPO May 9, 2019
Valuation
Valuation & price
$1.50as of May 17, 2026· -49.0% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.39
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$99.6M
Market cap
—
Revenue growth (YoY)
92.6%
Gross margin
-$49.3M
Free cash flow (USD)
-$47.6M
Net debt
Net cash position
34.8%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 15, 2026Filing
Equity Incentive Plan Amendment
- Quarterly reportMay 13, 2026Filing
10-Q Filed
- 8-K eventMay 13, 2026Filing
Earnings Release
- FinancingMay 13, 2026Filing
Securities Registration
- Insider sellApr 20, 2026Filing
Insider Sell $82K · 10b5-1 PlanOliveto Joseph · Director, President and CEO · $82.5K
Questions
Frequently asked questions
What is Milestone Pharmaceuticals Inc.'s market cap?
Milestone Pharmaceuticals Inc. (MIST) has a market capitalization of $99.6M.
What is MIST's P/E ratio?
A meaningful P/E ratio is not available for MIST — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is MIST's price-to-book (P/B) ratio?
MIST trades at 2.39 times book value per share.
Are insiders buying MIST stock?
SEC Form 4 filings show no open-market insider buys at Milestone Pharmaceuticals Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.